Atlas market file · Etf · United States
Invesco BulletShares 2028 High Yield Corporate Bond ETFBSJS
- Last close
- 21.768
- Change
- -0.03%
- 96-bar range
- 21.48 – 21.95
- As of
- 6 Aug 2026
Invesco BulletShares 2028 High Yield Corporate Bond ETF is an exchange-traded fund listed as BSJS on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-0.83% over the window).
Source rail: Yahoo Finance chart API (BSJS). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for BSJS. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
BSJS public profile
Exchange-traded fund. Invesco BulletShares 2028 High Yield Corporate Bond ETF is connected to current market context, cited company sources and its retained research file.
Invesco BulletShares 2028 High Yield Corporate Bond ETF trades as BSJS on NASDAQ. Invesco BulletShares 2028 High Yield Corporate Bond ETF (BSJS) has a latest verified close of 21.768, down 0.03%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. BSJS stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Invesco BulletShares 2028 High Yield Corporate Bond ETF today
The Invesco BulletShares 2028 high-return Corporate Bond ETF (BSJS) is marketed as a cost-effective, tax-efficient tool for meeting portfolio objectives, but its core is a high-return corporate bond basket expiring in 2028 with a 0.42% expense ratio that quietly erodes returns over time. The issuer, Invesco Distributors, Inc., is the US distributor for retail products, collective trust funds, and CollegeBound 529 plans, a title broad enough to cover almost any fund short of a charity or a pirate ship. The fund’s mandate is straightforward: hold high-return corporate bonds maturing by 2028 and charge 0.42% annually for the privilege. There is no magic in the wrapper, no alchemy in the expiry date, and no tax efficiency beyond the fund’s structure.
BSJS trades on Nasdaq under the ticker BSJS, a fact that sounds more exciting than it is. The fund’s holdings are not disclosed in its marketing, only in its SEC filings, where the excitement level is roughly equivalent to reading a telephone directory. The fund’s expense ratio of 0.42% is the clearest signal that this is a fee extraction product, not a yield amplification product. Invesco’s ETF centre lists BSJS alongside other funds like the Invesco Total Return Bond ETF (GTO), the Invesco QQQ Equal Weight ETF (QEW), and the Invesco S&P 500® Equal Weight ETF (RSP), but none of those funds charge 0.42% for high-return bonds expiring in 2028. The difference is the mandate, the maturity profile, and the fee structure-and the fee is the only part that moves the needle on your net return.
The SEC EDGAR fund search for BSJS confirms the fund’s identity, mandate, and expense ratio, but does not disclose its holdings or performance beyond what is required by regulation. The fund’s distributor, Invesco Distributors, Inc., is listed as the US distributor for Invesco’s retail products, collective trust funds, and CollegeBound 529 plans, a role that does not require the distributor to disclose the fund’s holdings or performance in marketing materials. The fund’s expense ratio is disclosed in the fund’s prospectus and on the SEC EDGAR search, but the holdings are only available in the fund’s N-PORT filings, which are dense, quarterly, and light on excitement.
For context on the fund’s fee and structure, the FINRA Fund Analyzer tool confirms the 0.42% expense ratio, but does not provide insights into the fund’s holdings or the credit quality of its issuers. The fund’s marketing emphasises cost-effectiveness and tax efficiency, but the reality is a high-return bond basket with a built-in expiry and a fee that compounds across every position. The fund’s Nasdaq page shows market activity, but the activity is in the wrapper, not the bonds. The fund’s SEC filings are the only place to find the truth, and the truth is a list of high-return corporate bonds with a 2028 maturity date and a 0.42% annual fee.
What changed this week? Nothing material. The fund’s expense ratio remains 0.42%, its mandate remains high-return corporate bonds maturing by 2028, and its distributor remains Invesco Distributors, Inc. The fund’s Nasdaq page updates its market activity, but the activity is in the wrapper, not the bonds. The fund’s SEC filings update its holdings and performance, but the updates are dense, quarterly, and light on excitement. The fund’s marketing remains unchanged, promising portfolio objectives while delivering a high-return bond basket with a built-in countdown and a fee that compounds across every position.
Sources & evidence · 8 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
BSJS technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on BSJS
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep BSJS research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
BSJS FAQ
What is Invesco BulletShares 2028 High Yield Corporate Bond ETF (BSJS)?Invesco BulletShares 2028 High Yield Corporate Bond ETF (BSJS) has a latest verified close of 21.768, down 0.03%, dated 6 Aug 2026. Use this page to check the price...
Invesco BulletShares 2028 High Yield Corporate Bond ETF (BSJS) has a latest verified close of 21.768, down 0.03%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for BSJS?Invesco BulletShares 2028 High Yield Corporate Bond ETF (BSJS) has a latest verified close of 21.768, down 0.03%, dated 6 Aug 2026. It brings the latest available...
Invesco BulletShares 2028 High Yield Corporate Bond ETF (BSJS) has a latest verified close of 21.768, down 0.03%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. BSJS stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the BSJS page updated?The BSJS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The BSJS public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for BSJS?The BSJS file starts with Nasdaq Trader and TradingView NASDAQ:BSJS. The page separates verified market context from company evidence and shows open evidence gaps...
The BSJS file starts with Nasdaq Trader and TradingView NASDAQ:BSJS. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on BSJS?Yes. The workstation can open BSJS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open BSJS, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this BSJS page investment advice?No. The BSJS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The BSJS page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
BSJS
Etf · evidence first